Cognition Therapeutics (CGTX) Q4 2024 Earnings

13NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.27
-0.18
-0.09
0

Details

Expected EPS
-0.196667
Actual EPS
-0.25
Surprise EPS
-0.05
Surprise Percent
+27.12%

Description

Cognition Therapeutics (CGTX) has reported earnings of -0.25 per share for Q4 2024.

0 Comments

Share your thoughts